Investors

Insider Transactions

Date Name Title Sorted Ascending Type Shares Traded Price Range
Sep 16, 2014 sanofi Beneficial Owner (10% or more) Buy 31,717 347.78 - 349.91
Oct 15, 2014 sanofi Beneficial Owner (10% or more) Automatic Buy 158,368 323.90 - 334.81
Oct 16, 2014 sanofi Beneficial Owner (10% or more) Automatic Buy 122,127 328.47 - 339.93
Dec 23, 2014 sanofi Beneficial Owner (10% or more) Buy 171,457 384.43 - 398.16
Dec 24, 2014 sanofi Beneficial Owner (10% or more) Buy 30,002 392.72 - 399.74
Mar 25, 2015 baker charles a Director Automatic Sell 5,000 452.45 - 457.21
Mar 25, 2015 baker charles a Director Option Execute 5,000 18.61
Mar 24, 2014 baker charles a Director Automatic Sell 15,000 300.09 - 313.40
Mar 24, 2014 baker charles a Director Option Execute 15,000 23.84
Nov 26, 2013 baker charles a Director Disposition (Non Open Market) 590 n/a
Sep 30, 2013 baker charles a Director Automatic Sell 15,000 302.46 - 319.13
Sep 30, 2013 baker charles a Director Option Execute 15,000 19.69
Jun 2, 2010 baker charles a Director Option Execute 5,000 25.43
Jul 1, 2011 baker charles a Director Automatic Sell 11,000 55.94 - 57.40
Jul 1, 2011 baker charles a Director Option Execute 11,000 28.81
Aug 10, 2011 baker charles a Director Option Execute 4,000 28.81
Feb 15, 2008 baker charles a Director Automatic Sell 10,000 18.67 - 19.06
Feb 15, 2008 baker charles a Director Option Execute 10,000 7.91
Feb 20, 2009 baker charles a Director Automatic Sell 10,000 18.16
Feb 20, 2009 baker charles a Director Option Execute 10,000 7.66
Showing 41-60 of 933 transactions Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47  See Previous 20 | See Next 20

Stock transaction information provided by EDGAR Online. Regeneron Pharmaceuticals, Inc. makes no representation or warranty with respect to any of the information contained herein, takes no responsibility for supplementing, updating or correcting any such information and shall have no liability with respect to any such information. This listing does not include derivatives, such as stock option grants or shares purchased through an employee stock purchase plan. For recent transactions, including derivative transactions, see our Section 16 SEC filings page.



Close
Form content here please :)